Viral Pathogenesis and Atherosclerosis

病毒发病机制和动脉粥样硬化

基本信息

项目摘要

DESCRIPTION (provided by applicant): Atherosclerosis is the major cause of cardiovascular disease. It is recognized as an inflammatory disorder involving endothelial cell (EC) dysfunction and infiltration of macrophages and lymphocytes into the arterial wall, but the events contributing to the chronic inflammation remain elusive. Atherosclerosis preferentially develops in regions of the arterial tree with branches and curvatures where blood flow is disturbed and shear stress is low and non-uniform. There is increasing evidence that laminar blood flow with high shear stress modulates gene expression in ECs to protect against atherosclerosis and inflammation and that disturbed flow and low shear stress upregulates proatherosclerotic and proinflammatory genes. It has long been suspected that human cytomegalovirus (HCMV) infection is a risk factor for vascular disease such as atherosclerosis and restenosis following angioplasty. The key question is what is the mechanism underlying HCMV's role in the disease process? We hypothesize that infection of ECs and generation of a specific T cell response may be key factors. The significance of this proposal is that we will use a novel multifaceted approach to study interactions among HCMV, ECs, and PBMCs under conditions of flow and shear stress that closely mirror the conditions found in arteries susceptible to atherosclerosis. I brings together the extensive expertise in the Deborah Spector lab on molecular and cellular biology of HCMV and the broad experience in the Stephen Spector lab on HCMV pathogenesis, immunology, and translational medicine to test our hypothesis and assess the potential role of HCMV in atherosclerosis. Two specific aims are proposed: In Aim 1, we will determine how HCMV infection of aortic ECs impacts on expression of adhesion factors and inflammatory cytokines and chemokines under high vs. low shear stress. In Aim 2, we will determine how HCMV infection of aortic ECs and differential adhesion of HCMV immunologically primed and naive PBMCs under different flow conditions contribute to EC dysfunction. The long-term objective of this proposal is to provide novel insights into the pathogenesis of atherosclerosis. Accomplishment of this goal will facilitate the development of new strategies designed to prevent and treat atherosclerotic disease.
描述(由申请人提供):动脉粥样硬化是心血管疾病的主要原因。它被认为是一种炎症性疾病,涉及内皮细胞(EC)功能障碍和巨噬细胞和淋巴细胞浸润到动脉壁中,但导致慢性炎症的事件仍然难以捉摸。动脉粥样硬化优先发生在具有分支和弯曲的动脉树区域,其中血流受到干扰并且剪切应力低且不均匀。有越来越多的证据表明,层流高切应力调节基因表达的EC,以防止动脉粥样硬化和炎症和干扰流和低切应力上调促动脉粥样硬化和促炎基因。人巨细胞病毒(human cytomegalovirus,HCMV)感染是血管疾病如动脉粥样硬化和血管成形术后再狭窄的危险因素。关键问题是HCMV在疾病过程中的作用机制是什么?我们推测内皮细胞的感染和特异性T细胞反应的产生可能是关键因素。该提案的意义在于,我们将使用一种新的多方面方法来研究在流动和剪切应力条件下HCMV,EC和PBMC之间的相互作用,这些条件密切反映了易患动脉粥样硬化的动脉中发现的条件。我汇集了Deborah Spector实验室在HCMV分子和细胞生物学方面的广泛专业知识,以及Stephen Spector实验室在HCMV发病机制,免疫学和转化医学方面的广泛经验,以测试我们的假设并评估HCMV在动脉粥样硬化中的潜在作用。提出了两个具体的目标:在目标1中,我们将确定HCMV感染的主动脉内皮细胞的粘附因子和炎症细胞因子和趋化因子的表达的影响,在高与低剪切应力。在目标2中,我们将确定HCMV感染的主动脉内皮细胞和HCMV免疫致敏和幼稚PBMC在不同的流动条件下的差异粘附如何导致EC功能障碍。这项提案的长期目标是提供新的见解动脉粥样硬化的发病机制。这一目标的实现将促进旨在预防和治疗动脉粥样硬化疾病的新策略的发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DEBORAH Hye SPECTOR其他文献

DEBORAH Hye SPECTOR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DEBORAH Hye SPECTOR', 18)}}的其他基金

Zika Virus Pathogenesis and Selective Autophagy Induction to Inhibit Virus Production
寨卡病毒发病机制和选择性自噬诱导抑制病毒产生
  • 批准号:
    9277152
  • 财政年份:
    2017
  • 资助金额:
    $ 23.25万
  • 项目类别:
Biologic Role of Cytomegalovirus in Endothelial Cell Inflammation and Atheroscler
巨细胞病毒在内皮细胞炎症和动脉粥样硬化中的生物学作用
  • 批准号:
    8895567
  • 财政年份:
    2014
  • 资助金额:
    $ 23.25万
  • 项目类别:
Role of CMV in Heart Disease of HIV-Infected Women and Perinatally Infected Youth
CMV 在 HIV 感染妇女和围产期感染青少年心脏病中的作用
  • 批准号:
    8915898
  • 财政年份:
    2014
  • 资助金额:
    $ 23.25万
  • 项目类别:
Disruption of Neural Stem Cell Homeostasis by Cytomegalovirus
巨细胞病毒破坏神经干细胞稳态
  • 批准号:
    8570815
  • 财政年份:
    2013
  • 资助金额:
    $ 23.25万
  • 项目类别:
Disruption of Neural Stem Cell Homeostasis by Cytomegalovirus
巨细胞病毒破坏神经干细胞稳态
  • 批准号:
    8661325
  • 财政年份:
    2013
  • 资助金额:
    $ 23.25万
  • 项目类别:
CMV 2012 - combined 4th Congenital Cytomegalovirus Conference and 14th Internatio
CMV 2012 - 第四届先天性巨细胞病毒会议和第 14 届国际巨细胞病毒会议合并
  • 批准号:
    8400272
  • 财政年份:
    2012
  • 资助金额:
    $ 23.25万
  • 项目类别:
Atherosclerosis: Cytomegalovirus, Shear Stress, and Endothelial Cells
动脉粥样硬化:巨细胞病毒、剪切应力和内皮细胞
  • 批准号:
    8192010
  • 财政年份:
    2011
  • 资助金额:
    $ 23.25万
  • 项目类别:
Atherosclerosis: Cytomegalovirus, Shear Stress, and Endothelial Cells
动脉粥样硬化:巨细胞病毒、剪切应力和内皮细胞
  • 批准号:
    8269800
  • 财政年份:
    2011
  • 资助金额:
    $ 23.25万
  • 项目类别:
Development of a Novel Vaccine Against Herpes Simplex Type 2
新型 2 型单纯疱疹疫苗的开发
  • 批准号:
    7914756
  • 财政年份:
    2009
  • 资助金额:
    $ 23.25万
  • 项目类别:
Disabling of the Anaphase Promoting Complex by Human Cytomegalovirus
人巨细胞病毒使后期促进复合物失活
  • 批准号:
    7712782
  • 财政年份:
    2009
  • 资助金额:
    $ 23.25万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.25万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.25万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.25万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 23.25万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 23.25万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 23.25万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 23.25万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 23.25万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 23.25万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 23.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了